Lonza to Build Capabilities for Drug Product Development Services Friday, February 05, 2016 Lonza is entering the field of Drug Product Development Services for customers by building its capabilities step-wise over the coming years.Genetic Mechanism Behind Cancer-Causing Mutations Thursday, February 04, 2016 Researchers at Indiana University has identified a genetic mechanism that is likely to drive mutations that can lead to cancer.Cofactor Genomics Acquires Narus Biotechnologies Thursday, February 04, 2016 Cofactor Genomics, a leader in RNA products and applications, announced today that they have acquired San Francisco, CA based Narus Biotechnologies, a biomarker development company focused on creating RNA diagnostic tests for neurological diseases that can help inform therapeutic selection for patients with Multiple Sclerosis, Alzheimer’s and Parkinson’s.How to Unlock Inaccessible Genes Thursday, February 04, 2016 An international team of biologists has discovered how specialized enzymes remodel the extremely condensed genetic material in the nucleus of cells in order to control which genes can be used. Viral Gene Editing System Corrects Genetic Liver Disease Wednesday, February 03, 2016 Penn study has implications for developing safe therapies for an array of rare diseases via new gene cut-and-paste methods.Mapping Regulatory Elements Wednesday, February 03, 2016 Systematically searching DNA for regulatory elements indicates limits of previous thinkingNew Biomarker to Assess Stem Cells Developed Wednesday, February 03, 2016 A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.'Junk' DNA Plays Role in Preventing Breast Cancer Wednesday, February 03, 2016 Supposed "junk" DNA, found in between genes, plays a role in suppressing cancer, according to new research by Universities of Bath and Cambridge. GenomeFIRST Awarded $400K Grant Wednesday, February 03, 2016 Geisinger Health System has been awarded a $400,000 grant from the Robert Wood Johnson Foundation (RWJF) to support GenomeFIRST Medicine, a unique program to help patients and providers understand and use genomic information in their health care.